Myeloma Paper of the Day, June 26th, suggested by Robert Orlowski
Robert Orlowski shared on X:
“Myeloma Paper of the Day: Systematic review of modeling approaches to evaluate treatments for relapsed/refractory myeloma finds they rarely followed an individual patient approach, and there is a growing need for modeling complex treatment strategies.”
Source: Robert Orlowski/X
Authors: Andreas Freitag, Grammati Sarri, An Ta, Laura Gurskyte, Dasha Cherepanov and Luis G. Hernandez.
Other posts featuring Robert Orlowski on OncoDaily.
Robert Orlowski holds multiple positions at The University of Texas MD Anderson Cancer Center, including Chairman, Ad Interim Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma/Myeloma and Experimental Therapeutics within the Division of Cancer Medicine.
Additionally, he chairs the SWOG Barlogie/Salmon Myeloma Committee, which is part of the National Clinical Trials Network, dedicated to advancing new therapies and understanding the biology of myeloma.
